ES8700568A1 - Procedimiento para obtener complejos fviii-vwf para uso te- rapeutico - Google Patents

Procedimiento para obtener complejos fviii-vwf para uso te- rapeutico

Info

Publication number
ES8700568A1
ES8700568A1 ES547051A ES547051A ES8700568A1 ES 8700568 A1 ES8700568 A1 ES 8700568A1 ES 547051 A ES547051 A ES 547051A ES 547051 A ES547051 A ES 547051A ES 8700568 A1 ES8700568 A1 ES 8700568A1
Authority
ES
Spain
Prior art keywords
fviii
preparation
vwf complex
resulting products
therapeutical use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES547051A
Other languages
English (en)
Other versions
ES547051A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMMUNOTECH SA
Immunotech SAS
Original Assignee
IMMUNOTECH SA
Immunotech SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMMUNOTECH SA, Immunotech SAS filed Critical IMMUNOTECH SA
Publication of ES8700568A1 publication Critical patent/ES8700568A1/es
Publication of ES547051A0 publication Critical patent/ES547051A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L55/00—Devices or appurtenances for use in, or in connection with, pipes or pipe systems
    • F16L55/26—Pigs or moles, i.e. devices movable in a pipe or conduit with or without self-contained propulsion means
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
    • H04N5/00—Details of television systems
    • H04N5/76—Television signal recording
    • H04N5/91—Television signal processing therefor
    • H04N5/92—Transformation of the television signal for recording, e.g. modulation, frequency changing; Inverse transformation for playback
    • H04N5/9201—Transformation of the television signal for recording, e.g. modulation, frequency changing; Inverse transformation for playback involving the multiplexing of an additional signal and the video signal
    • H04N5/9206—Transformation of the television signal for recording, e.g. modulation, frequency changing; Inverse transformation for playback involving the multiplexing of an additional signal and the video signal the additional signal being a character code signal
    • H04N5/9207—Transformation of the television signal for recording, e.g. modulation, frequency changing; Inverse transformation for playback involving the multiplexing of an additional signal and the video signal the additional signal being a character code signal for teletext
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mechanical Engineering (AREA)
  • Combustion & Propulsion (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Signal Processing (AREA)
  • Multimedia (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DEL COMPLEJO FVIII/VWF COMO FACTOR ANTIHEMOFILICO A; PARA USO TERAPEUTICO. CONSISTE EN FIJAR EL COMPEJO FVIII/VWF EN UN MEDIO FISIOLOGICO, SOBRE UN ANTICUERPO MONOCLONAL Y LIBERARLOS DESPUES POR UN MEDIO ELUYENTE CAPAZ DE DISOCIAR LOS ENLACES ENTRE EL ANTICUERPO MONOCLONAL Y EL COMPLEJO, RECOGIENDOSE ESTE EN UNA FORMA PURIFICADA EN ALTO GRADO. DE USO TERAPEUTICO CON ACTIVIDAD ANTIHEMOFILICA A Y WILLEBRAND.
ES547051A 1984-09-18 1985-09-17 Procedimiento para obtener complejos fviii-vwf para uso te- rapeutico Expired ES8700568A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8414480A FR2570276B1 (fr) 1984-09-18 1984-09-18 Procede d'obtention du complexe fviii/vwf a usage therapeutique et produits en resultant

Publications (2)

Publication Number Publication Date
ES8700568A1 true ES8700568A1 (es) 1986-10-16
ES547051A0 ES547051A0 (es) 1986-10-16

Family

ID=9307917

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547051A Expired ES8700568A1 (es) 1984-09-18 1985-09-17 Procedimiento para obtener complejos fviii-vwf para uso te- rapeutico

Country Status (9)

Country Link
US (1) US4670543A (es)
EP (1) EP0179006B1 (es)
JP (2) JPH0649720B2 (es)
AT (1) ATE69955T1 (es)
CA (1) CA1257211A (es)
DE (1) DE3584817D1 (es)
ES (1) ES8700568A1 (es)
FR (1) FR2570276B1 (es)
WO (1) WO1986001718A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543145A (en) * 1984-09-17 1996-08-06 Baxter International, Inc. Pharmaceutical composition and method for the suppression of factor VIII inhibitor production
US8597910B1 (en) 1985-04-11 2013-12-03 Children's Medical Center Corporation DNA encoding Von Willebrand Factor (VWF) and methods and cells for producing VFW, and VFW produced by the DNA, methods and cells
DE3707213A1 (de) * 1987-03-06 1988-09-15 Behringwerke Ag Verfahren zur herstellung von faktor viii:c-mangelplasma und ein so erhaltenes mangelplasma
US5177191A (en) * 1987-12-21 1993-01-05 Miles, Inc. Gel filtration of factor VIII
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
FR2665449B1 (fr) * 1990-08-02 1995-04-14 Aquitaine Developp Transf Sang Procede de fabrication de facteur von willebrand ayant une tres haute purete, depourvu en majeure partie de facteur antihemophilique (fviiic), et facteur von willebrand ainsi obtenu, ainsi qu'une composition pharmaceutique le contenant.
US5760183A (en) * 1989-02-17 1998-06-02 Association D'aquitaine Pour De Developpment De La Transfusion Sanguine Et Des Recherches Hematologiques Process for the manufacture of very high-purity antithaemophilic factor (FVIIIC), and von Willebrand factor, and pharmaceutical compositions containing same
US5110907A (en) * 1989-08-01 1992-05-05 Alpha Therapeutic Corporation Factor viii complex purification using heparin affinity chromatography
JPH0427865A (ja) * 1989-12-21 1992-01-30 Kurita Water Ind Ltd 血液凝固因子用分離剤およびその製造方法
AT403991B (de) * 1990-04-04 1998-07-27 Atomic Austria Gmbh Alpinschi
AT403992B (de) * 1991-02-22 1998-07-27 Head Sport Ag Ski
AT403764B (de) 1996-03-15 1998-05-25 Immuno Ag Stabiler faktor viii/vwf-komplex
AT403765B (de) * 1996-04-12 1998-05-25 Immuno Ag Verfahren zur herstellung einer präparation enthaltend einen hochgereinigten komplex
AT406867B (de) 1997-02-27 2000-10-25 Immuno Ag Verfahren zur gewinnung von hochreinem vwf oder faktor viii/vwf-komplex
US20060068454A1 (en) * 2004-09-27 2006-03-30 Sysmex Corporation Method of inactivating blood coagulation factor and blood coagulation factor-inactivated sample

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies

Also Published As

Publication number Publication date
JPS62500520A (ja) 1987-03-05
FR2570276B1 (fr) 1987-09-04
CA1257211A (fr) 1989-07-11
FR2570276A1 (fr) 1986-03-21
ES547051A0 (es) 1986-10-16
JPH0649720B2 (ja) 1994-06-29
EP0179006B1 (fr) 1991-12-04
JPH06107700A (ja) 1994-04-19
DE3584817D1 (de) 1992-01-16
WO1986001718A1 (fr) 1986-03-27
ATE69955T1 (de) 1991-12-15
JPH06102680B2 (ja) 1994-12-14
EP0179006A1 (fr) 1986-04-23
US4670543A (en) 1987-06-02

Similar Documents

Publication Publication Date Title
ES8700568A1 (es) Procedimiento para obtener complejos fviii-vwf para uso te- rapeutico
GR1000023B (el) Καρβαμικος φαινυλεστηρ.
ES267712Y (es) Panal desechable despues del uso.
MX171205B (es) Almohadilla para limpieza manual y metodo para su fabricacion
DK69890D0 (da) Monoklonale antistoffer, der er reaktive med cachetin
IT1111874B (it) Pezzo intermedio con un detettore di luce per un collegamento disimpegnabile ad innesto,impiegato per il collegamento di una fibra per la conduzione di luce con una sorgente di luce a semiconduttore
DE3481035D1 (de) Ibuprofen, flurbiprofen und deren therapeutische verwendung.
NO162179C (no) Monoklonale antistoffer for anvendelse in vitro.
AU3614384A (en) Anti-idiotype antibodies & their use in inducing immulogical response to viruses & tumours
DK164088D0 (da) Syntetiske peptidantigener til paavisning af hiv-1-infektion
DE3668061D1 (de) Heliumleckdetektor fuer kleine elemente.
IT1151649B (it) Carrello con piatto ribaltabile, in particolare per apparecchiature di smistamento
IT8121489A0 (it) Catalizzatore per poliolefina ad elevata efficacia e procedimento per fabbricare e usare lo stesso.
DK150458C (da) Vibrationstransportoer, fortrinsvis elevatortransportoer, med skrueformet transportbane
ES267715Y (es) "panal desechable despues del uso".
DE3381467D1 (de) Plasmaproteinkonzentrate mit reduzierter thrombogenizitaet und deren verwendung in klinischer ersatztherapie.
IT8719331A0 (it) Mandrino per il fissaggio di cella per la centrifugazione del sangue, e simili.
DE68908664D1 (de) Vorrangsschaltung für einen im medizinischen bereich verwendeten tisch.
ATE71149T1 (de) Monoklonale antikoerper.
FI881879A7 (fi) Valonsäteiden säteilyttämislaite lääketieteelliseen käyttöön.
ES2025562T3 (es) Vendajes laminados.
ES519767A0 (es) Procedimiento para el aprovechamiento de fibras hiladas en fusion.
NO891610L (no) Natursteinplate med holdeelement for ryggsiden.
IT1115507B (it) Specchio convergente,in particolare per "centrali solari",procedimento per la sua fabbricazione e dispositivo per l'attuazione del detto procedimento
IT1135048B (it) Procedimento per disincrinare e cannello multiforme per la messa in opera del procedimento